|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
|
AMRX
|
Amneal Pharmaceuticals, Inc.
|
US
|
NYSE
|
|
ANVS
|
Annovis Bio, Inc.
|
US
|
NYSE
|
|
ATHE
|
Alterity Therapeutics Limited
|
US
|
NASDAQ
|
|
BCLI
|
Brainstorm Cell Therapeutics Inc.
|
US
|
NASDAQ
|
|
CCM
|
Concord Medical Services Holdings Limited ADS
|
US
|
NYSE
|
|
CGTX
|
Cognition Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
IGC
|
India Globalization Capital Inc.
|
US
|
AMEX
|
|
IKT
|
Inhibikase Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMPL
|
Impel NeuroPharma, Inc.
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
NAVB
|
Navidea Biopharmaceuticals, Inc.
|
US
|
AMEX
|
|
NERV
|
Minerva Neurosciences, Inc
|
US
|
NASDAQ
|
|
NMTC
|
NeuroOne Medical Technologies Corporation
|
US
|
NASDAQ
|
|
NRSN
|
NeuroSense Therapeutics Ltd.
|
US
|
NASDAQ
|
|
PMN
|
ProMIS Neurosciences Inc.
|
US
|
NASDAQ
|